Patents Assigned to Lavipharm Laboratories Inc.
  • Publication number: 20070298090
    Abstract: Dosage forms of a nicotine delivery system are disclosed in which a mucoadhesive film, made up of one or more non-microbial hydrocolloid(s) and an effective dose of nicotine, dissolves when applied intraorally to release the nicotine which is absorbed through the oramucosac and directly reaches systemic circulation. Methods for preparing various versions of the dosage forms are disclosed. Methods to assist smoking cessation or provide substitutes for smoking by administrating the dosage form are also provided.
    Type: Application
    Filed: September 7, 2007
    Publication date: December 27, 2007
    Applicant: LAVIPHARM LABORATORIES, INC.
    Inventors: Li-Lan CHEN, Alfred LIANG
  • Patent number: 7247315
    Abstract: The invention relates to transdermal delivery patches comprising a drug-containing drug reservoir wherein the drug reservoir comprises a plasticizer composition selected to adjust the rate of drug flux out of the transdermal delivery patch device. The invention also specifically relates to methods of producing the transdermal delivery patches of the invention, the methods comprising the use of an alcohol drug dispersing agent. The invention further specifically relates to methods of treating acute and chronic pain and methods of inducing and maintaining analgesia with the transdermal delivery patches of the invention.
    Type: Grant
    Filed: August 15, 2002
    Date of Patent: July 24, 2007
    Assignee: Lavipharm Laboratories Inc.
    Inventors: Teletha A. Brown, James Osborne, Michael Rudella, Brian Hunt, Vinod Malik
  • Publication number: 20070087981
    Abstract: The products and methods of the present invention provide a means for increasing the solubility and bioavailability of active agents. More particularly the invention provides compositions containing active agents as water-soluble complexes with glycyrrhizin, and methods of preparing such complexes. The invention further provides methods for the preparation of highly water soluble complex dosage forms.
    Type: Application
    Filed: October 19, 2006
    Publication date: April 19, 2007
    Applicant: Lavipharm Laboratories, Inc.
    Inventors: Li-Lan Chen, Li Tao, Alfred Liang
  • Patent number: 7138135
    Abstract: Bioadhesive, closed-cell foam film, sustained release, delivery devices for administering an active agent or combination of active agents to a subject are provided. Methods for making such delivery devices and methods for using such delivery devices offering the controlled and sustained release of an active agent or combination of active agents to a subject, preferably a near zero-order release, are also provided.
    Type: Grant
    Filed: June 24, 2004
    Date of Patent: November 21, 2006
    Assignee: Lavipharm Laboratories Inc.
    Inventors: Li-Lan H. Chen, Li Tao, Alfred Liang, Xu Zheng
  • Patent number: 7125564
    Abstract: The products and methods of the present invention provide a means for increasing the solubility and bioavailability of active agents. More particularly the invention provides compositions containing active agents as water-soluble complexes with glycyrrhizin, and methods of preparing such complexes. The invention further provides methods for the preparation of highly water soluble complex dosage forms.
    Type: Grant
    Filed: February 8, 2002
    Date of Patent: October 24, 2006
    Assignee: Lavipharm Laboratories, Inc.
    Inventors: Li-Lan H. Chen, Li Tao, Alfred Liang
  • Patent number: 7087240
    Abstract: Devices and methods for treatment of erectile dysfunction and methods of manufacture and of use are provided. The devices include filmogenic material, a therapeutic agent, a permeation enhancer, and other ingredients. An embodiment of the device includes a backing and a release liner.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: August 8, 2006
    Assignee: Lavipharm Laboratories Inc.
    Inventor: Spiros Fotinos
  • Patent number: 6723671
    Abstract: Fragrance emitting articles are provided along with methods of making and using the same. The fragrance emitting articles provided contain microcapsules of a fragrance, which microcapsules are associated with the fragrance emitting article without the addition of a binder. The invention also relates to methods of making the subject fragrance emitting articles and methods of using those articles.
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: April 20, 2004
    Assignee: Lavipharm Laboratories Inc.
    Inventors: Yelena Zolotarsky, David O'Halloran, Florence Bernard, Pradeep Thaker
  • Publication number: 20040013731
    Abstract: Oral drug complex microparticles containing: a pharmaceutical active having a nitrogen moiety and an anionic methacrylic acid copolymer; wherein the oral drug complex micropaticles resist dissolution or dissociation upon exposure to saliva, but which rapidly dissociate in gastric acid and which rapidly dissolve in intestinal fluid. Oral drug delivery devices containing said oral drug complex microparticles are provided. Processes for producing said oral drug complex microparticles and methods for treating patients including administering said oral drug delivery devices thereto are also provided.
    Type: Application
    Filed: April 8, 2003
    Publication date: January 22, 2004
    Applicant: Lavipharm Laboratories Inc.
    Inventors: Li-Lan H. Chen, Alfred Liang, Xu Zheng
  • Publication number: 20030219479
    Abstract: Drug delivery devices for administering an active agent or a combination of active agents to a subject are provided.
    Type: Application
    Filed: April 8, 2003
    Publication date: November 27, 2003
    Applicant: Lavipharm Laboratories Inc.
    Inventors: Li-Lan H. Chen, Alfred Liang
  • Publication number: 20030118653
    Abstract: Quick dissolving oral mucosal drug delivery devices having a mucosal surface-coat-forming inner layer disposed between two moisture barrier coating layers for administering an active agent or combination of active agents to a subject are provided. Methods for making such quick dissolving oral mucosal drug delivery devices and to methods for using such quick dissolving oral mucosal drug delivery devices offering the measured and controlled release of an active agent or combination of active agents to a subject are also provided.
    Type: Application
    Filed: June 10, 2002
    Publication date: June 26, 2003
    Applicant: Lavipharm Laboratories Inc.
    Inventors: Li-Lan H. Chen, Alfred Liang, Xu Zheng, Hsueh-Ling Wu
  • Publication number: 20030086954
    Abstract: Compositions for forming a peelable, cosmetic film on the skin of a subject are provided. The compositions provided contain 3 to 30 wt % pullulan and 3 to 30 wt % polyvinyl alcohol; wherein the combination of pullulan and polyvinyl alcohol constitute 6 to 33 wt % of the composition. The invention also relates to a method of forming a peelable, cosmetic film on the skin of a subject including applying a composition to the skin of the subject, wherein the composition contains 3 to 30 wt % pullulan and 3 to 30 wt % polyvinyl alcohol; wherein the combination of pullulan and polyvinyl alcohol constitute 6 to 33 wt % of the composition.
    Type: Application
    Filed: September 26, 2002
    Publication date: May 8, 2003
    Applicant: Lavipharm Laboratories Inc.
    Inventors: David P. O'Halloran, Yelena Zolotarsky
  • Publication number: 20030082221
    Abstract: Compositions for forming a visible and distinctive cosmetic film on the skin of a subject are provided. The compositions provided contain 3 to 15 wt % pullulan. The invention also relates to a method of forming a visible and distinctive cosmetic film on the skin of a subject including applying a composition to the skin of the subject, wherein the composition contains 3 to 15 wt % pullulan.
    Type: Application
    Filed: September 26, 2002
    Publication date: May 1, 2003
    Applicant: Lavipharm Laboratories Inc.
    Inventors: David P. O'Halloran, Yelena Zolotarsky
  • Patent number: 6552024
    Abstract: Mucosal surface-coat-forming film dosage units containing a water-soluble hydrocolloid, an effective dose of an active agent and a mucosal adhesion enhancer; wherein the active agent is encapsulated within a polymer which is chemically or physically distinct from the hydocolloid; wherein the mucosal adhesion enhancer is a starch graft copolymer; wherein the film exhibits a dry tack value of less than 3.5 g, a wet tack of greater than 35 g, a gelation temperature that is greater than 70° C. for a 2% polymer solution, a dry film thickness of less than 20 mil, a water content of 0.5 to 10%, a tensile strength greater than 1500 psi, a modulus in the range of 35,000 to 300,000 psi, a % elongation of less than 20%, a tear probagation resistance of 0.001 to 1 N, and a dissolution time in the range of 1 to 600 seconds upon application to an oral mucosal surface.
    Type: Grant
    Filed: November 5, 1999
    Date of Patent: April 22, 2003
    Assignee: Lavipharm Laboratories Inc.
    Inventors: Li-Lan H. Chen, William R. Pfister, Donald W. Renn, Thitiwan Buranachokpaisan, James Osborne, Hock Seng Tan, Li Tao
  • Publication number: 20030068378
    Abstract: Mucosal surface-coat-forming film dosage units containing a water-soluble hydrocolloid, an effective dose of a sexual dysfunction active agent and a mucosal adhesion enhancer, wherein the mucosal adhesion enhancer is a starch graft copolymer.
    Type: Application
    Filed: March 5, 2002
    Publication date: April 10, 2003
    Applicant: Lavipharm Laboratories Inc.
    Inventors: Li-Lan H. Chen, William R. Pfister, Donald W. Renn, Thitiwan Buranachokpaisan, James Osborne, Hock Seng Tan, Li Tao
  • Publication number: 20030068376
    Abstract: Dosage forms of a nicotine delivery system are disclosed in which a mucoadhesive film, made up of one or more non-microbial hydrocolloid(s) and an effective dose of nicotine, dissolves when applied intraorally to release the nicotine which is absorbed through the oramucosae and directly reaches systemic circulation. Methods for preparing various versions of the dosage forms are disclosed. Methods to assist smoking cessation or provide substitutes for smoking by administrating the dosage form are also provided.
    Type: Application
    Filed: April 18, 2002
    Publication date: April 10, 2003
    Applicant: Lavipharm Laboratories Inc.
    Inventors: Li-Lan H. Chen, Alfred Liang
  • Publication number: 20030060479
    Abstract: The invention relates to transdermal delivery patches comprising a drug-containing drug reservoir wherein the drug reservoir comprises a plasticizer composition selected to adjust the rate of drug flux out of the transdermal delivery patch device. The invention also specifically relates to methods of producing the transdermal delivery patches of the invention, the methods comprising the use of an alcohol drug dispersing agent. The invention further specifically relates to methods of treating acute and chronic pain and methods of inducing and maintaining analgesia with the transdermal delivery patches of the invention.
    Type: Application
    Filed: August 15, 2002
    Publication date: March 27, 2003
    Applicant: Lavipharm Laboratories Inc.
    Inventors: Teletha A. Brown, James Osborne, Michael Rudella, Brian Hunt, Vinod Malik
  • Publication number: 20030007944
    Abstract: Cosmetic and/or therapeutic film former compositions for a topical use and for optional delivery of active ingredients to the skin are provided. More particularly, film forming compositions are provided, containing 1 to 50 wt % polyurethane, preferably polyurethane-1; at least 0.01 wt %, but less than 2.0 wt %, cellulose and 0.05 to 5.0 wt % magnesium aluminum silicate; wherein the film forming composition forms a uniform mist when discharged from a spray bottle or pump sprayer. A method for applying a film forming composition to an individual's skin is also provided including spraying the film forming composition onto the skin, wherein the film forming composition contains 1 to 50 wt % polyurethane; at least 0.01 wt %, but less than 2.0 wt %, cellulose and 0.05 to 5.0 wt % magnesium aluminum silicate; and wherein the film forming composition forms a uniform mist when sprayed.
    Type: Application
    Filed: April 3, 2002
    Publication date: January 9, 2003
    Applicant: Lavipharm Laboratories Inc.
    Inventors: David O'Halloran, Yelena Zolotarsky
  • Publication number: 20020147201
    Abstract: The products and methods of the present invention provide a means for increasing the solubility and bioavailability of active agents. More particularly the invention provides compositions containing active agents as water-soluble complexes with glycyrrhizin, and methods of preparing such complexes. The invention further provides methods for the preparation of highly water soluble complex dosage forms.
    Type: Application
    Filed: February 8, 2002
    Publication date: October 10, 2002
    Applicant: Lavipharm Laboratories Inc.
    Inventors: Li-Lan H. Chen, Li Tao, Alfred Liang
  • Publication number: 20020127254
    Abstract: Solid gel film compositions for local and systemic delivery of active substances through the skin or mucosal epithelial layer of a subject are provided. More particularly, delivery discs are provided containing a uniform mixture, wherein the uniform mixture contains a filmogenic polymer and a therapeutically effective dose of an active substance, wherein the delivery disc is a single uniform layer device which is non-tacky and which dissolves onto a skin tissue skin tissue with few drops of water or lotion or mucosal epithelial tissue of a subject when applied thereto. Methods for administering an active substance to a subject using a delivery disc of the present invention are provided. Methods for preparing the delivery discs of the present invention are also provided.
    Type: Application
    Filed: January 7, 2002
    Publication date: September 12, 2002
    Applicant: Lavipharm Laboratories Inc.
    Inventors: Spiros Fotinos, David O 'Halloran, Yelena Zolotarsky
  • Patent number: 6346255
    Abstract: Devices for the improvement of skin appearance are provided, said devices including a pad with a backing layer, a release layer, and a vehicle located therebetween, the vehicle containing a cosmetic formulation and a skin permeation enhancer, wherein the skin permeation enhancer includes a plant polar lipid. The invention also relates to a method of improving skin appearance using the devices of the invention.
    Type: Grant
    Filed: January 15, 1999
    Date of Patent: February 12, 2002
    Assignee: Lavipharm Laboratories Inc.
    Inventor: Spiros Fotinos